Madrid

• A Study of PHN-012 in Patients With Advanced Solid Tumors Recruiting
  2025-523756-31-00 1 2026-03-26 Advanced Solid Tumors
• A study to test how well PLENVU®, a bowel cleansing medicine, works in children and teenagers before they have a colonoscopy exam Recruiting
  2025-522046-42-00 5 2026-03-24 Colonic disease
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) Recruiting
  2025-522674-36-00 5 2026-03-24 Metabolic Dysfunction-Associated Steatotic Liver Disease
• An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease Recruiting
  2025-521036-11-00 5 2026-03-23 Immune system disseases
• A study to test whether nerandomilast can help slow down changes in the lung in people with a family history of pulmonary fibrosis Recruiting
  2025-522383-33-00 5 2026-03-23 Interstitial lung diseases
• An early phase trial of RPTR-1-201 in Advanced Solid Tumors Recruiting
  2025-524010-28-00 7 2026-03-20 Advanced Solid Tumor
• (Title in lay language): A trial to learn how safe AZD0516 is and how well it works with and without other cancer treatments in adults with … Recruiting
  2024-520026-11-00 7 2026-03-19 Metastatic Prostate Cancer
• Phase III Study of Rilvegostomig in Combination withBevacizumab with or without Tremelimumab as First-lineTreatment of Hepatocellular Carcin … Recruiting
  2024-518210-81-00 5 2026-03-18 Advanced Hepatocellular Carcinoma
• ADCX-020 for the treatment of patients with locally advanced or metastatic cancers Recruiting
  2025-523959-65-00 1 2026-03-17 Locally Advanced or Metastatic Solid Tumors
• A clinical trial to test if an investigational combination therapy with BNT326 and BNT327 is safe and potentially beneficial for people with … Recruiting
  2024-519344-32-00 9 2026-03-16 Non-small Cell Lung Cancer
• A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3 Recruiting
  2025-521621-33-00 6 2026-03-16 Metastatic Melanoma
• A clinical study of islatravir and ulonivirine for people with HIV-1 who have not been treated before (MK-8591B-062) Recruiting
  2025-522519-40-00 10 2026-03-16 HIV
• A Study of Evorpacept (ALX148) in Patients with Metastatic HER2-Positive Breast Cancer Recruiting
  2025-522012-16-00 4 2026-03-13 Breast Cancer
• A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known t … Recruiting
  2025-522613-26-00 7 2026-03-13 Advanced Solid Cancers
• A Long-term Extension Study of ORX750 in Participants with Narcolepsy and Idiopathic Hypersomnia Recruiting
  2025-522987-34-00 4 2026-03-13 Narcolepsy and Idiopathic Hypersomnia
• Prevention of Recurrent C. difficile Infection Study with AZD5148 Monoclonal Antibody Recruiting
  2025-521416-19-00 4 2026-03-12 Recurrence of Clostridioides difficile Infection
• Pasritamig With Docetaxel vs Docetaxel in Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting
  2025-522713-29-00 5 2026-03-12 Metastatic Castration-resistant Prostate Cancer (mCRPC)
• OCEAN(a)-CCTA - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction -Coronary Computed Tomography Angiography trial Recruiting
  2025-521117-88-00 5 2026-03-11 Cardiovascular Disease
• FINE-START; A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the eff … Recruiting
  2025-523075-32-00 5 2026-03-09 chronic kidney disease
• A Phase 2 study of zanidatamab in patients with HER2-expressing tumors Recruiting
  2024-516551-41-00 4 2026-03-06 Patients with HER2-expressing solid tumors
• Beamion LUNG-3: A study to test whether zongertinib helps people with surgically removed, non-small cell lung cancer with HER2 mutations com … Recruiting
  2025-521284-12-00 5 2026-03-05 Non-small cell lung cancer
• An Open-Label Extension, Multi-Centered, Phase 2 Trial of TEV-56286 (Emrusolmin) for Multiple System Atrophy Recruiting
  2025-521642-14-00 4 2026-03-05 Multiple System Atrophy
• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab ( Switch-Up ) Recruiting
  2025-523347-35-00 11 2026-03-05 Atopic Dermatitis
• A clinical study to find the optimal dose of an investigational treatment called BNT323 when used in combination with another investigationa … Recruiting
  2024-517979-20-00 9 2026-03-04 Advanced Breast Cancer Metastatic Breast Cancer

Showing 697–720 of 3,550 trials